HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,977,499 | -25.0% | 77,945 | -29.2% | 0.01% | -41.7% |
| Q2 2023 | $3,972,173 | +1329.5% | 110,124 | +1413.5% | 0.01% | +1100.0% |
| Q1 2023 | $277,870 | -97.0% | 7,276 | -95.5% | 0.00% | -97.2% |
| Q4 2022 | $9,232,253 | +3762.9% | 162,254 | +2581.9% | 0.04% | +3500.0% |
| Q3 2022 | $239,000 | -96.0% | 6,050 | -95.5% | 0.00% | -97.0% |
| Q2 2022 | $5,973,000 | +541.6% | 135,753 | +481.6% | 0.03% | +725.0% |
| Q1 2022 | $931,000 | -72.6% | 23,341 | -72.4% | 0.00% | -55.6% |
| Q4 2021 | $3,399,000 | +82.6% | 84,531 | +84.8% | 0.01% | +80.0% |
| Q3 2021 | $1,861,000 | +211.2% | 45,742 | +218.9% | 0.01% | +25.0% |
| Q1 2021 | $598,000 | -9.0% | 14,345 | -6.8% | 0.00% | -20.0% |
| Q4 2020 | $657,000 | -64.3% | 15,391 | -77.6% | 0.01% | -83.3% |
| Q2 2020 | $1,840,000 | +12.0% | 68,646 | -25.9% | 0.03% | +200.0% |
| Q4 2019 | $1,643,000 | +495.3% | 92,668 | +420.7% | 0.01% | +400.0% |
| Q3 2019 | $276,000 | -58.3% | 17,798 | -53.8% | 0.00% | -66.7% |
| Q2 2019 | $662,000 | -76.1% | 38,513 | -77.6% | 0.01% | -79.3% |
| Q1 2019 | $2,769,000 | +119.2% | 171,972 | +99.3% | 0.03% | +93.3% |
| Q4 2018 | $1,263,000 | -42.7% | 86,298 | -28.9% | 0.02% | -42.3% |
| Q3 2018 | $2,206,000 | +127.4% | 121,392 | +111.1% | 0.03% | +100.0% |
| Q2 2018 | $970,000 | +117.0% | 57,500 | +151.9% | 0.01% | +85.7% |
| Q1 2018 | $447,000 | -66.9% | 22,824 | -65.7% | 0.01% | -70.8% |
| Q4 2017 | $1,350,000 | +433.6% | 66,621 | +237.1% | 0.02% | +380.0% |
| Q2 2017 | $253,000 | +68.7% | 19,763 | +59.4% | 0.01% | -50.0% |
| Q3 2016 | $150,000 | -75.3% | 12,400 | -64.7% | 0.01% | -85.1% |
| Q4 2015 | $608,000 | +378.7% | 35,100 | +166.3% | 0.07% | -45.5% |
| Q4 2014 | $127,000 | – | 13,180 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |